Mark G. Carter

3.6k total citations · 1 hit paper
26 papers, 2.6k citations indexed

About

Mark G. Carter is a scholar working on Molecular Biology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark G. Carter has authored 26 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark G. Carter's work include Pluripotent Stem Cells Research (16 papers), CRISPR and Genetic Engineering (8 papers) and Reproductive Biology and Fertility (6 papers). Mark G. Carter is often cited by papers focused on Pluripotent Stem Cells Research (16 papers), CRISPR and Genetic Engineering (8 papers) and Reproductive Biology and Fertility (6 papers). Mark G. Carter collaborates with scholars based in United States, Spain and Japan. Mark G. Carter's co-authors include Minoru S.H. Ko, Alexei A. Sharov, Toshio Hamatani, Dawood B. Dudekula, Vincent VanBuren, Carole A. Stagg, Geppino Falco, Hidenori Akutsu, Takiko Daikoku and Sudhansu K. Dey and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Mark G. Carter

26 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamics of Global Gene Expression Changes during Mouse Preimplantation Development

2004 712 citations Toshio Hamatani, Mark G. Carter et al. Developmental Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark G. Carter United States	18	2.0k	770	507	301	267	26	2.6k
Carol A. Brenner United States	23	1.4k 0.7×	732 1.0×	290 0.6×	323 1.1×	365 1.4×	38	2.3k
Go Nagamatsu Japan	21	1.6k 0.8×	831 1.1×	401 0.8×	285 0.9×	75 0.3×	35	2.4k
Yasuhide Ohinata Japan	20	2.6k 1.3×	543 0.7×	910 1.8×	181 0.6×	86 0.3×	29	3.1k
Rabindranath De La Fuente United States	23	2.3k 1.1×	1.5k 1.9×	789 1.6×	114 0.4×	238 0.9×	43	3.0k
Amy Ralston United States	24	3.8k 1.9×	946 1.2×	619 1.2×	216 0.7×	243 0.9×	45	4.3k
Veronica J. Roberts United States	29	2.0k 1.0×	884 1.1×	502 1.0×	237 0.8×	124 0.5×	41	3.3k
G. Ian Gallicano United States	28	1.4k 0.7×	505 0.7×	311 0.6×	96 0.3×	116 0.4×	57	2.3k
Giuseppe Pilia United States	23	2.0k 1.0×	449 0.6×	1.5k 3.0×	139 0.5×	268 1.0×	41	2.9k
Lynn M. Wiley United States	24	1.1k 0.5×	647 0.8×	350 0.7×	164 0.5×	156 0.6×	58	1.7k
Minna Heikkilä Finland	16	1.3k 0.6×	434 0.6×	1.1k 2.1×	178 0.6×	74 0.3×	21	2.1k

Countries citing papers authored by Mark G. Carter

Since Specialization

Citations

This map shows the geographic impact of Mark G. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Carter more than expected).

Fields of papers citing papers by Mark G. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Carter. The network helps show where Mark G. Carter may publish in the future.

Co-authorship network of co-authors of Mark G. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Carter. A scholar is included among the top collaborators of Mark G. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Carter. Mark G. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smagghe, Benoit J., Mark G. Carter, Daniel M. Miller, et al.. (2025). Effective CAR T-cell targeting of an MUC1 cleavage product. Journal for ImmunoTherapy of Cancer. 13(5). e010577–e010577. 1 indexed citations

Bamdad, Cynthia, Yuan Yuan, Jennifer M. Specht, et al.. (2022). Phase I/II first-in-human CAR T–targeting MUC1 transmembrane cleavage product (MUC1*) in patients with metastatic breast cancer.. Journal of Clinical Oncology. 40(16_suppl). TPS1130–TPS1130. 7 indexed citations

Smagghe, Benoit J., Andrew K. Stewart, Mark G. Carter, et al.. (2013). MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve State. PLoS ONE. 8(3). e58601–e58601. 21 indexed citations

Kim, Chul, Joonghoon Park, Tomokazu Amano, et al.. (2012). Established Preblastocyst- and Blastocyst-Derived ES Cell Lines Have Highly Similar Gene Expression Profiles, Despite Their Differing Requirements for Derivation Culture Conditions. Cellular Reprogramming. 14(1). 1–7. 1 indexed citations

Tang, Yong, Yan Luo, Zongliang Jiang, et al.. (2012). Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation. Stem Cells. 30(12). 2645–2656. 64 indexed citations

Kim, Chul, Tomokazu Amano, Joonghoon Park, et al.. (2009). Improvement of Embryonic Stem Cell Line Derivation Efficiency with Novel Medium, Glucose Concentration, and Epigenetic Modifications. Cloning and Stem Cells. 11(1). 89–100. 16 indexed citations

Du, Fuliang, Jie Xu, Jifeng Zhang, et al.. (2008). Beneficial Effect of Young Oocytes for Rabbit Somatic Cell Nuclear Transfer. Cloning and Stem Cells. 11(1). 131–140. 23 indexed citations

Carter, Mark G., Carole A. Stagg, Geppino Falco, et al.. (2008). An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. Gene Expression Patterns. 8(3). 181–198. 65 indexed citations

Das, Biswajit, Liquan Cai, Mark G. Carter, et al.. (2006). Gene expression changes at metamorphosis induced by thyroid hormone in Xenopus laevis tadpoles. Developmental Biology. 291(2). 342–355. 104 indexed citations

10.

Matoba, Ryo, Hitoshi Niwa, Shinji Masui, et al.. (2006). Dissecting Oct3/4-Regulated Gene Networks in Embryonic Stem Cells by Expression Profiling. PLoS ONE. 1(1). e26–e26. 137 indexed citations

11.

Carter, Mark G., Alexei A. Sharov, Vincent VanBuren, et al.. (2005). Transcript copy number estimation using a mouse whole-genome oligonucleotide microarray. Genome biology. 6(7). R61–R61. 101 indexed citations

12.

Yoshikawa, Toshiyuki, Yulan Piao, Ryo Matoba, et al.. (2005). High-throughput screen for genes predominantly expressed in the ICM of mouse blastocysts by whole mount in situ hybridization. Gene Expression Patterns. 6(2). 213–224. 65 indexed citations

13.

Hamatani, Toshio, Mark G. Carter, Alexei A. Sharov, & Minoru S.H. Ko. (2004). Dynamics of Global Gene Expression Changes during Mouse Preimplantation Development. Developmental Cell. 6(1). 117–131. 712 indexed citations breakdown →

14.

Bektas, Arsun, Shepherd H. Schurman, Alexei A. Sharov, et al.. (2004). Klotho gene variation and expression in 20 inbred mouse strains. Mammalian Genome. 15(10). 759–767. 11 indexed citations

15.

Hamatani, Toshio, Geppino Falco, Mark G. Carter, et al.. (2004). Age-associated alteration of gene expression patterns in mouse oocytes. Human Molecular Genetics. 13(19). 2263–2278. 424 indexed citations

16.

Hamatani, Toshio, Takiko Daikoku, Haibin Wang, et al.. (2004). Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proceedings of the National Academy of Sciences. 101(28). 10326–10331. 203 indexed citations

17.

Carter, Mark G., Yulan Piao, Dawood B. Dudekula, et al.. (2003). The NIA cDNA Project in mouse stem cells and early embryos. Comptes Rendus Biologies. 326(10-11). 931–940. 11 indexed citations

18.

Chen, Wenyong, Mark G. Carter, Craig N. Morrell, et al.. (2003). Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nature Genetics. 33(2). 197–202. 170 indexed citations

19.

Carter, Mark G., Toshio Hamatani, Alexei A. Sharov, et al.. (2003). In Situ-Synthesized Novel Microarray Optimized for Mouse Stem Cell and Early Developmental Expression Profiling. Genome Research. 13(5). 1011–1021. 88 indexed citations

20.

VanBuren, Vincent, Yulan Piao, Dawood B. Dudekula, et al.. (2002). Assembly, Verification, and Initial Annotation of the NIA Mouse 7.4K cDNA Clone Set. Genome Research. 12(12). 1999–2003. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact